|
|
|
|
|
|
The latest stem cells news from News Medical |
|
|
|
 | |
Newly Launched resDetectTM dsRNA ELISA Kit
During the in vitro transcription (IVT) of mRNA products, Double-Stranded RNA (dsRNA) is frequently generated as a by-product, impacting vaccine safety and effectiveness.
Ensure the quality of mRNA products with the high-sensitivity dsRNA ELISA Kit! With a detection limit of 8.988 pg/mL, this kit ensures the quality and safety of mRNA products by specifically identifying dsRNA without cross-reacting with ssRNA or dsDNA. The Kit recognizes >40 bp dsRNA (including modified types) and is ideal for precise and reliable quality control of RNA products.
| |
|
|
|
|
 | | A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical trial reported in Nature. | | | | B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it can affect people of any age. | | | | A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than before. | | | | Utilizing CRISPR-Cas9, scientists reconstitute live African swine fever virus from synthetic genomes, accelerating vaccine development for this deadly virus. | | | | Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers at the University of Illinois Urbana-Champaign report. | |
|
|
|
|
 | | How would you rate today's newsletter?
| |
|
|
|
 | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|